The systemic inflammatory response is associated with survival in patients with a variety of
cancers. This inflammatory response is measured in the peripheral blood, and can be …

Inflammation is increasingly reported to be associated with the prognosis of patients with
cancers. And the prognostic role of neutrophil-to-lymphocyte ratio (NLR) in patients with …

Background Inflammation was considered to perform crucial roles in the development and
metastasis of malignancies. A heightened neutrophil-lymphocyte ratio has been described …

Purpose To evaluate the diagnostic values of systemic immune-inflammation index (SII) and
neutrophil–lymphocyte ratio (NLR) in patients with localized prostate cancer (PCa). Methods …

Objective and Background Increasing evidence suggests that inflammation plays an
essential role in cancer development and progression. The inflammation marker neutrophil …

Purpose To investigate the association between preoperative systemic immune-
inflammation index (SII) and neutrophil–lymphocyte ratio (NLR) and oncological outcomes …

Background The neutrophil-to-lymphocyte ratio (NLR) is a measure of systemic inflammation
and a prognostic factor for multiple malignancies. This study assesses the value of the NLR …

Background Inflammation plays a critical role in the development and progression of
cancers. The advanced lung cancer inflammation index (ALI) is thought to be able to reflect …

Neutrophil-to-lymphocyte ratio (NLR), a simple marker of systemic inflammatory response,
has been demonstrated as an independent prognosticator for some solid malignancies …

Background: Inflammation and cancer are closely related to each other. As a parameter that
can reflect inflammation and host immune reaction, elevated blood neutrophil to lymphocyte …